CQ6 Are pMDIs with spacers more effective than nebulizers in the multiple-dose inhalation of beta2-agonists for treating acute asthma exacerbation in children?

Author:

Sugimoto Mayumi1,Suzuki Shuichi2,Natsume Osamu3,Arakawa Hirokazu4

Affiliation:

1. Department of Pediatrics, Tokushima University Hospital

2. Department of Pediatrics, Shimoshizu National Hospital

3. Department of Pediatrics, Hamamatsu University School of Medicine

4. Department of Pediatrics, Gunma University Graduate School of Medicine

Publisher

Japanese Society of Pediatric Allergy and Clinical Immunology

Subject

Ocean Engineering

Reference24 articles.

1. 3) Cates CJ, Welsh EJ, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2013 ; 9 : CD000052.

2. 4) Batra V, Sethi GR, Sachdev HP. Comparative efficacy of jet nebulizer and metered dose inhaler with spacer device in the treatment of acute asthma. Indian Pediatr 1997 ; 34 : 497-503.

3. 5) Chong Neto HJ, et al. Different inhaler devices in acute asthma attacks : a randomized, double-blind, placebo-controlled study. J Pediatr (Rio J) 2005 ; 81 : 298-304.

4. 6) Chou KJ, Cunningham SJ, Crain EF. Metered-dose inhalers with spacers versus nebulizers for pediatric asthma. Arch Pediatr Adolesc Med 1995 ; 149 : 210-215.

5. 7) Direkwatanachai C, et al. Comparison of salbutamol efficacy in children-via the metered-dose inhaler (MDI) with Volumatic (R) spacer and via the dry powder inhaler, Easyhaler (R), with the nebulizer-in mild to moderate asthma exacerbation : a multicenter, randomized study. Asian Pac J Allergy Immunol 2011 ; 29 : 25-33.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Japanese guidelines for childhood asthma 2020;Allergology International;2020-07

2. Commentary Japanese Pediatric Guideline for the Treatment and Management of Asthma 2017 Chapter 8 Management of acute exacerbation;Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology;2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3